Abstract The gammaherpesvirus alcelaphine herpesvirus 1 (AlHV-1) causes fatal malignant catarrhal fever (MCF) in susceptible species including cattle, but infects its reservoir host, wildebeest, without causing disease. Pathology in cattle may be influenced by virus-host cell interactions mediated by the virus glycoproteins. Cloning and expression of a haemagglutinin-tagged version of the AlHV-1 glycoprotein B (gB) was used to demonstrate that the AlHV-1-specific monoclonal antibody 12B5 recognised gB and that gB was the main component of the gp115 complex of AlHV-1, a glycoprotein complex of five components identified on the surface of AlHV-1 by immunoprecipitation and radiolabelling. Analysis of AlHV-1 virus particles showed that the native form of gB was detected by mAb 12B5 as a band of about 70 kDa, whilst recombinant gB expressed by transfected HEK293T cells appeared to be subject to additional cleavage and incomplete post-translational processing. Antibody 12B5 recognised an epitope on the N-terminal furin-cleaved fragment of gB on AlHV-1 virus particles. It could be used to detect recombinant and virus-expressed gB on western blots and on the surface of infected cells by flow cytometry, whilst recombinant gB was detected on the surface of transfected cells by immunofluorescence. Recombinant gB has potential as an antigen for ELISA detection of MCF virus infection and as a candidate vaccine antigen.
Introduction
Malignant catarrhal fever (MCF) is a fatal lymphoproliferative disease of cattle, deer, bison and other ungulates, caused by ruminant gammaherpesviruses of the genus Macavirus [1] . Alcelaphine herpesvirus 1 (AlHV-1), which is among the best studied of the MCF viruses, naturally infects wildebeest, causing MCF among in-contact cattle in sub-Saharan Africa. The other major cause of MCF worldwide is ovine herpesvirus 2 (OvHV-2), which naturally infects domestic sheep [2] . The MCF viruses infect their natural hosts without obvious clinical signs, causing a lifelong, latent infection. In the wildebeest, AlHV-1 cellfree virus appears to be shed in nasal secretions and other body fluids during occasional recrudescence of lytic infection in adults, but the major source of infectious virus appears to be wildebeest calves that shed virus for a prolonged period during their first few months of life. This virus presents a major infectious disease challenge for incontact cattle, and Massai herdsmen move their cattle to poorer upland grazing to avoid wildebeest during the calving season [3, 4] .
MCF in cattle is a dramatic, fatal lymphoproliferative disease that causes lymphocyte accumulation and necrosis in multiple organs. It is characterised by fever, inappetence, ocular and nasal discharge, lesions of the buccal cavity and muzzle, diarrhoea and depression. Cattle may survive for a week or more after the appearance of the first clinical signs, while bison and deer generally die after a few days. Currently, there is no treatment or vaccine commercially available for MCF.
AlHV-1, unlike OvHV-2, is the only MCF virus that currently can be propagated in culture and has therefore been used as a model for the sheep-associated form of the disease. The virus genome has been sequenced [5] and is very similar to the genome of OvHV-2 [6] . Small-animal models of AlHV-1 infection are available and have been characterised [7, 8] . Extended passage of pathogenic AlHV-1 leads to attenuation [9] , and this is associated with rearrangements within the virus genome [10] . Attenuated AlHV-1 has recently been shown to protect cattle from fatal challenge with pathogenic virus and therefore represents a candidate vaccine for MCF [11, 12] . The attenuated and pathogenic AlHV-1 strains have recently been characterised by proteomic methods, demonstrating that there are few major differences between the strains [13] .
As part of our studies to understand the basis of MCF pathology in cattle, we have been studying the antigenic capsid proteins of AlHV-1 [14] . However, interactions between the virus and host are also likely to be influenced by the membrane glycoproteins of the virus, which are responsible for interactions with cell-surface receptors on target cell types and fusion of virus and cell membranes. The gp115 glycoprotein complex of AlHV-1 was defined by immunoprecipitation with monoclonal antibody (mAb) 12B5 [15] and mAb 152-A [16] as having components of approximately 115, 110, 105, 78 and 48 kDa. Further analysis demonstrated that this complex appeared to be composed of a single polypeptide that was glycosylated to generate the mature 115-kDa form, which was then cleaved to produce a covalently linked complex comprising 78 kDa and 48 kDa chains in the virus particle [15] . Recent proteomic analysis of polyacrylamide-gel-fractionated AlHV-1 virus proteins [13] showed that glycoprotein B (gB) was found in two bands with relative mobility estimated at 80 kDa and 50 kDa, respectively. Examination of the gB peptides identified in the two bands showed that the 80-kDa band contained N-terminal peptides, and the 50-kDa band contained C-terminal peptides, relative to the position of a furin cleavage site [13] . The existing published data therefore support the hypothesis that mAb 12B5 recognises an epitope on gB and that the 78-kDa and 48-kDa bands identified previously are the furin-cleaved N-and C-terminal fragments of gB.
The aims of this work were to confirm the interaction of mAb 12B5 with AlHV-1 gB by expression of a recombinant, epitope-tagged polypeptide and to characterise the expression and antigenicity of the recombinant gB polypeptide.
Materials and methods

Cells and virus
The AlHV-1 C500 strain was propagated in bovine turbinate (BT) cells grown in Iscove's modified Dulbecco's medium (IMDM; Life Technologies, Paisley, UK) with 5 % foetal bovine serum (FBS) and 2 % L-glutamine. BT cells were infected with pathogenic AlHV-1 C500 at a multiplicity of infection (MOI) of 3, and virus-infected cells were harvested after 3-5 days. Cell-associated virus particles were isolated after three rounds of freeze-thaw treatment, clarified by centrifugation and stored in batches at -80°C until required. Representative aliquots of virus were titrated as described previously [11] .
Human embryonic kidney 293T (HEK293T) cells were used for transfection studies following previous experiments that had shown that this cell line provided both a high frequency of transfection and a high level of expression of MCF virus genes [17, 18] . For transfection and subsequent protein expression, cells were grown in IMDM with 10 % FBS and 2 % L-glutamine. For fluorescence microscopy, sterile coverslips were first treated with 500 ll of poly-L-lysine for 20 minutes to improve cell adherence. Excess poly-L-lysine was removed, and the coverslips were dried in a 37°C incubator for 1 hour. Cells were seeded onto coverslips at 2 9 10 5 per well of a 24-well dish in IMDM before transfection. After 6 hours at 37°C and 5 % CO 2 , the medium was changed to serum-free Opti-MEM (Life Technologies).
Amplification and cloning of the gB gene
The gene encoding gB (ORF8 [5] ) from AlHV-1 was expressed in recombinant form as follows: ORF8 was amplified from AlHV-1 strain C500 DNA by PCR using the primers ORF8FwdAsc (5'-GGC GCG CCG GCG CAC ACA GGT AGC ACA GTC T-3') and ORF8RevFse (5'-GGC CGG CCC GAC ACC AGT GCT CTC AAA AGA GT-3') and KOD hot-start DNA polymerase (Merck, Nottingham, UK). The 2.6-kbp fragment was inserted into pCR4-blunt-TOPO (Life Technologies), and the DNA sequence of the resulting clones was determined using flanking and internal primers. A verified ORF8 fragment was excised using restriction enzymes AscI and NgoMIV and inserted into the mammalian expression vector pVR-MCS-HA, derived from pVR1255 (a kind gift from Vical Inc. [19] ). To generate pVR-MCS-HA, a synthetic 218-bp double-stranded cassette encoding a ribosome binding site with a start codon, a multiple cloning site, a TEV protease cleavage site and a C-terminal triple-HA (haemagglutinin) epitope tag (TOP Gene Technologies, Montreal Canada; accession number FN553440) was inserted between the NotI and BamHI sites of pVR1255. The correct structure of the resulting AlHV-1 gB expression vector (pVR-ORF8-HA) was confirmed by restriction enzyme analysis.
Antibodies
Monoclonal antibody 12B5 was raised against whole AlHV-1 virus antigen in BALB/c mice and was shown to be specific for the viral major glycoprotein complex in western blots and immunoprecipitation experiments [15] . For western blotting of HA-tagged proteins, a directly conjugated high-affinity rat monoclonal anti-HA-peroxidase (3F10; Roche) was used. Secondary antibodies used for western blotting were HRP-conjugated polyclonal goat anti-mouse immunoglobulins (Dako, Glostrup, Denmark) and polyclonal rabbit anti-bovine IgG-HRP (Sigma). For flow cytometry and fluorescence microscopy, the following antibodies were used: mouse anti-HA IgG3 (Abcam); Alexa 488-conjugated goat anti-mouse IgG3 (Life Technologies); mouse anti-tubulin IgG1 (Abcam); Alexa 555-conjugated goat anti-mouse IgG1 (Life Technologies).
Transfection
Briefly, HEK293T cells were grown in IMDM containing 5 % FBS and 2 mM L-glutamine to 70 % confluence before being transfected with plasmid DNA (1 lg per 10 6 cells) using Lipofectamine 2000 (Life Technologies) according to the manufacturer's protocol. The transfection reagent was replaced with fresh medium after four hours, and transfected cells were allowed to grow for up to 72 h before harvesting the cells and medium.
Protein extracts for western blotting and ELISA were made 48 h post-transfection by lysing single-cell suspensions in 0.8 % CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) in Tris-buffered saline, pH 8.3.
Electrophoresis and western blotting
Protein extracts (approx. 10 lg per lane) were fractionated in denaturing, reducing 10 % NuPAGEÒ Bis-Tris gels (Life Technologies). Protein bands were visualised with SimplyBlue SafeStain (Life Technologies) or transferred to nitrocellulose using the X-cell II semi-wet Blot module in 19 NuPAGE Transfer buffer (Life Technologies) containing 10 % or 20 % methanol, following manufacturer's guidelines. Nitrocellulose membranes were blocked in PBST (19PBS, 0.05 % [v/v] TWEEN20 [Sigma]) containing 5 % non-fat milk powder (5 % milk) and then washed several times in PBST. For HA-tag detection, proteins were probed with anti-HA-HRP according to the manufacturer's instructions. Detection of gB with monoclonal antibody 12B5 was done with a 1:1000 dilution of affinity-purified 12B5 followed by incubation with HRPconjugated goat anti-mouse Ig. For detection by antibodies from MCF-vaccinated or infected animals, blood serum or plasma was diluted 1:100 in PBST containing 5 % milk. Bound antibodies were detected with polyclonal rabbit anti-cow immunoglobulin-HRP. Finally, blots were washed several times with PBST and then incubated for 5 min in SuperSignal West Pico Chemiluminescent Substrate (Pierce) before visualisation of bands using an ImageQuant LAS4000 imaging system (GE Healthcare).
Proteomic analysis
The identification of recombinant AlHV-1 gB fractionated by gel electrophoresis was done by liquid chromatographyelectrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) as described previously [13, 14] . Briefly, protein bands excised from PAGE gels were subjected to standard in-gel destaining, reduction, alkylation and trypsinolysis, followed by liquid chromatography interfaced with a 3-D high-capacity ion trap mass spectrometer (Esquire HCTplusTM, Bruker Daltonics). Mass spectral data were analysed using the Mascot V2.2 (Matrix Science) search algorithm against viral and mammalian subsections of the NCBI non-redundant protein sequence databases. Protein identification within a gel band required a minimum of two peptides to be matched, with each peptide containing an unbroken ''b'' or ''y'' ion series of at least four amino acid residues.
ELISA
Extracts of transfected or untransfected HEK293T cells were prepared as described above, and serial dilutions (in 0.1 M carbonate buffer, pH 9.6) were used to coat triplicate wells of 96-well microtitre plates (Greiner, high binding). After washing in PBST, detection of the MCF antigen was assayed using a 1:200 dilution of an AlHV-1-positive plasma pool that had previously been used as a control in analysis of vaccinated cattle [12] . Antibody bound in each well was detected using 1:1000 rabbit anti-bovine IgGhorseradish peroxidase conjugate (Sigma) and colorimetric detection using tetramethylbenzidine (TMB; Sigma).
Average optical density at 450 nm was used as the measure of ELISA response.
Flow cytometry
BT cells were infected with pathogenic AlHV-1 C500 at a MOI of 3. After 24 h, the infected cells were harvested and stained with mAb 12B5 or isotype-matched control antibody (VPM21 [20] ), followed by phycoerythrin-conjugated anti-mouse IgG1 secondary antibody. After staining, the cells were washed twice in FACS buffer and fixed in PBS/0.02 % sodium azide before storing in the dark and on ice.
Samples were acquired using a FACSCalibur instrument (Becton Dickinson, NJ, USA) equipped with 488-nm argon-ion and 635-nm red diode lasers and CellQuest software. Forward (FSC) and side scatter (SSC) were collected as linear signals, and fluorescent emissions were collected on a four-decade logarithmic scale. A bandpass filter for phycoerythrin was employed to collect the signal in fluorescence channel 2 (FL2, 585 ± 21 nm). A minimum of 10,000 cells were acquired for each sample by gating cells on forward and side scatter.
Fluorescence microscopy
Cells for fluorescence microscopy were incubated for 48 hours after transfection or seeding onto coverslips before fixing with 4 % paraformaldehyde (Sigma) in PBS at room temperature for 1 hour. Cells were washed twice with PBS and once with immunofluoresence buffer (IFF; 2 % FBS, 1 % BSA in PBS). Cells were stored at 4°C in IFF.
Fixed cells were permeabilised using 0.5 % Triton X-100 in PBS for 10 minutes at room temperature. Cells were then rinsed twice with PBS and once with IFF. Cells were incubated in primary antibody diluted in IFF for 40 minutes at room temperature. Cells were then washed twice with PBS and once with IFF before incubation with the appropriate secondary antibody diluted in IFF for 40 minutes in the dark at room temperature. Cells were washed three times with PBS, refixed with 4 % PFA for 20 minutes, and then rinsed three times with PBS, with the final wash containing DAPI. The cells were rinsed with water and mounted onto slides with Vectashield (Vector Labs) and sealed with clear nail varnish.
Stained cells were visualised using a motorised Zeiss axiovert 200M inverted epifluorescence microscope with apotome and an axiocam MR3 camera. The following Zeiss filter sets were used; set 38H (excitation BP470/40, beam splitter FT495, emission BP525/50) set 43 (excitation BP 545/25, beam splitter FT 570, emission BP 605/70), set 49 (excitation G 365, beam splitter FT395, emission BP 445/50) and set 50 (excitation BP640/30, beam splitter FT 660, emission BP 690/50). Image analysis was undertaken using Zeiss axiovision software.
Results
Expression of AlHV-1 gB
To address the hypothesis that mAb 12B5 recognised an epitope on AlHV-1 glycoprotein B, the AlHV-1 ORF8 gene, encoding gB, was cloned into a haemagglutinin (HA)-tagged expression vector based on pVR1255 [19] . The resulting construct, pVR-ORF8-HA, was introduced into HEK293T cells by transfection, and protein extracts were made 48 h post-transfection. A western blot of wholecell extracts probed with anti-HA-HRP conjugate showed that AlHV-1 gB was detected as three bands with apparent M r of approximately 100 kDa, 50 kDa and 20 kDa (Fig. 1A) . These bands presumably corresponded to fulllength gB and two cleaved forms carrying the C-terminal HA-tag. An equivalent gel, carrying extracts of HEK293T cells expressing gB and BT cells infected with pathogenic AlHV-1 virus, was blotted using mAb 12B5. This showed that whilst a single major band with M r of about 70 kDa was recognised in the virus extract by 12B5, three bands were recognised within the recombinant gB extract with approximate M r of 100 kDa, 70 kDa and 60 kDa (Fig. 1B) . This confirmed that mAb 12B5 recognised gB and suggested that the HA-tagged 50-kDa and 20-kDa cleaved products of gB seen in Fig. 1A had lost the 12B5 epitope. The differences in bands recognised by mAb 12B5 between the virus -infected and the gB-transfected cell extracts (Fig. 1B) likely reflect differences in post-translational processing between the two cell lines, including both glycosylation and furin cleavage. While gB in the mature AlHV-1 virion appeared to be almost fully cleaved by furin, with only a faint band at the uncleaved *100-kDa position, the recombinant protein expressed in HEK293T cells was mostly uncleaved, with a smaller proportion of the gB appearing as bands with lower M r . This is in accord with observations with other gammaherpesviruses that cleavage of gB is closely associated with virion assembly [21] . The detection of two 12B5-detected bands with mobility 60-80 kDa in the recombinant gB lane (Fig. 1B) is in keeping with previous observations that furin cleavage of the 115-kDa and 110-kDa components of the major envelope glycoprotein complex in infected cells gave rise to bands with M r 78 kDa and 66 kDa, respectively [15] . This supports the published evidence that HEK293T cells express furin [22] and suggests that limited furin cleavage of recombinant gB can occur in the absence of virion assembly. Thus, recombinant gB expressed in HEK293T cells appears to be subject to both incomplete post-translational modification and additional proteolytic cleavage to produce the lower bands observed in Fig. 1A and B. Attempts to express recombinant gB in AlHV-1-infected cells have been unsuccessful to date. This may reflect the poor levels of transfection achievable in the AlHV-1-permissive cell lines tested or the silencing of the recombinant gB construct in AlHV-1-infected cells.
Proteomic analysis of gB fragments
To confirm the identity of the HA-tagged 50-kDa and 20-kDa bands (Fig. 1A) , they were subject to proteomic analysis following excision of the bands from SDS-PAGE of affinity-purified recombinant gB. MS/MS analysis did not provide any evidence of gB-specific peptides in the 20-kDa band, but the 50-kDa band yielded multiple gBspecific peptides that were mainly in the C-terminal direction from position 300 (Online Resource 1). These observations suggest that recombinant gB may be cleaved at sites on both sides of the furin cleavage site in addition to any furin cleavage that occurs. These data also suggest that the mAb 12B5 epitope is likely to be in the N-terminal direction from position 300. The absence of detectable gB-specific peptides in the 20-kDa HA-tagged band may reflect a lack of suitable peptides for mass spectrometry in the C-terminal portion of the protein. This fragment is likely to include the transmembrane and cytoplasmic regions of gB and the triple-HA tag, which may influence the ionisation or detection of gB peptides. This is supported by the lack of sequenced peptides from the C-terminal region (residues 700-860) of the 50-kDa gB-HA fragment and the low abundance of mass-matched peptides (Online Resource 1).
Detection of recombinant gB using sera from infected animals
To further study the antigenic properties of AlHV-1 gB, we analysed the reactivity of affinity-purified recombinant gB in western blots with antibodies from naturally infected wildebeest, from cattle MCF cases caused by AlHV-1 or OvHV-2, and from cattle immunised with the attenuated AlHV-1 vaccine [11] (Fig. 2A) . This demonstrated that all three recombinant gB bands were recognised by antibodies from both immunised and MCF-affected animals and showed cross-reactivity between AlHV-1 gB and OvHV-2-specific serum. These observations were confirmed by ELISA analysis of extracts of HEK293T cells transfected with pVR-ORF8-HA using an AlHV-1-positive antibody pool. This showed that MCF-specific antibodies could detect gB at dilutions down to at least 1/200 (0.05) of a crude extract of transfected HEK293T cells, whilst an equivalent extract containing a non-antigenic HA-tagged recombinant protein (ORF25 [14] ) was not significantly different from an extract of untransfected HEK293T cells (Fig. 2B) .
Detection of gB expression by flow cytometry and fluorescence microscopy
Having confirmed that mAb 12B5 recognised recombinant and native glycoprotein B in western blots and ELISA, we then tested whether it could detect expression of gB on the surface of productively infected cells. BT cells were infected with pathogenic AlHV-1, harvested after 24 h and stained with mAb 12B5 for analysis by flow cytometry (FACS). About 10 % of the BT cells expressed the 12B5 epitope (Fig. 3) , showing that mAb 12B5 could recognise the gB antigen in its native conformation and that gB was expressed on the surface of infected cells within 24 h.
The sub-cellular localisation of recombinant gB in transfected HEK293T cells was also confirmed by fluorescence microscopy (Online Resource 2). Staining with anti-HA showed that gB in transfected cells was detected mainly at the cell surface and that this localisation could be inhibited by treatment of the cells with brefeldin A, which inhibits intracellular transport (data not shown).
Discussion
These studies have shown for the first time that the polypeptides that form the gp115 glycoprotein complex of AlHV-1, identified on infected cells as five bands with M r 115-48 kDa [15, 16] , are derived from glycoprotein B, which is post-translationally modified and cleaved by furin during assembly into virus particles. The observation that recombinant gB expressed in HEK293T cells is poorly cleaved by furin and appears to be susceptible to degradation by other proteases suggests that virus assembly may be an essential part of the correct processing of gB. This is in accord with the known properties of gB in other herpesviruses, where association of gB with the gH/gL glycoprotein pair constitutes the core fusion machinery, while additional viral glycoprotein components of the fusion complex may act as cell-type-specific receptors [23] . It is notable that a recombinant OvHV-2 gB fusion polypeptide expressed in transfected cells was also subject to proteolysis, revealing bands of about 110 and 50 kDa [24] when blotted with an epitope tag antibody. Recombinant gB (in addition to other MCF virus antigenic proteins [14, 24] ) has been suggested as a good candidate for a recombinant vaccine for MCF, and the observation that AlHV-1 gB is recognized by OvHV-2-specific antiserum suggests that cross-protection might occur.
Immunisation of rabbits with OvHV-2 gB induced antibodies that reduced the infectivity of OvHV-2 in an in vivo assay [24] . As gB is a known target for herpesvirus neutralization [25] , and because mAbs that are now known to be specific for AlHV-1 gB have been shown to have virus neutralizing activity [15, 16] , it will be of interest to determine whether recombinant AlHV-1 gB can induce virus-neutralizing antibodies and protect immunized animals from malignant catarrhal fever. This work is currently ongoing.
The data presented here confirm the gB specificity of mAb 12B5 [15] and suggest that other mAbs with specificity for the gp115 complex of AlHV-1 are also likely to recognize epitopes on gB [15, 16] . Notably, the mAb 152A described by Li and colleagues [16] recognized a polypeptide with M r * 45 kDa under denaturing conditions. It is now likely that the epitope recognized by this mAb is on the C-terminal furin cleaved fragment of gB. Previous studies and the work presented here have demonstrated that mAb 12B5 is virus neutralizing and can detect gB in various assays, including immunoprecipitation, ELISA, western blot, flow cytometry and fluorescence microscopy. Attempts to visualize gB expression by immunohistochemistry of fixed tissue sections from MCFaffected cattle and rabbits have been unsuccessful to date (data not shown), suggesting that mAb 12B5 is not suitable for this application or that gB is not expressed in MCF-affected tissues. However, this versatile reagent has considerable potential for use in diagnostic applications, for analysis of the AlHV-1 fusion machinery, and for analysis of glycoprotein expression in AlHV-1 infection and MCF.
